article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

And I think of the analogy of, like, cancer screening. The stopping the cancer screening doesn’t have that same sort of momentum. I’m an internist, so when I hospitalize patients, 1 in 8 of my patients now takes pregabalin or gabapentin. Eric 20:51 And your deprescribing was on hospital discharge. in the U.S.

article thumbnail

Gun Violence

Maine Academy of Family Physicians

This site provides resources and downloadable toolkits to preserve firearm legacy and maintain safety. Users can navigate pre-deployment preparation, on-the-ground assistance, post-deployment resources, and more—at the touch of a button from the home screen. LINK to article

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Psychological Issues in Palliative Care: Elissa Kozlov and Des Azizoddin

GeriPal

Analyzing the Health and Retirement Study, she found 60% of older adults screened positive for depression in the last year of life (related study here ). We saw that around 60% of people were screening positive for depression in the last month before death. Or is it that I’m just not screening? That’s a lot.

article thumbnail

Episode 285: Anti-Racism in Medicine Series – Episode 21 – Psychosocial and Cultural Considerations for Providing Healthcare to Immigrant and Refugee Populations

The Clinical Problem Solvers

ICE and Policing — Instances of immigration enforcement in healthcare settings are rare, and when they do happen they can look like patients being interrogated at the bedside or even being arrested as they step out of the hospital just after visiting someone. Opinion: Covid-19 Shows Us Why We Should Keep ICE Out of Hospitals.

article thumbnail

MedTech Conference Download

FDA Law

We also heard from Dr. Suzanne Baron, Director of Interventional Cardiology Research at Lahey Hospital and Medical Center. These are important considerations as FDA routinely asks sponsors to ensure their protocols are diverse, not just in the subjects recruited, screened, and enrolled, but also in users and those who carry out the protocols.

Medical 59